表紙
市場調查報告書

中國的冠狀動脈介入治療 (CI)、經皮冠狀動脈介入治療 (PCI) 設備市場:考察、趨勢、預測 (2020∼2024年)

China Coronary Intervention (CI) & Percutaneous Coronary Intervention (PCI) Device Market: Insights, Trends & Forecast (2020-2024)

出版商 Koncept Analytics 商品編碼 929339
出版日期 內容資訊 英文 93 Pages
訂單完成後即時交付
價格
中國的冠狀動脈介入治療 (CI)、經皮冠狀動脈介入治療 (PCI) 設備市場:考察、趨勢、預測 (2020∼2024年) China Coronary Intervention (CI) & Percutaneous Coronary Intervention (PCI) Device Market: Insights, Trends & Forecast (2020-2024)
出版日期: 2020年03月23日內容資訊: 英文 93 Pages
簡介

中國的PCI設備市場在2020年∼2024年間,預測將以11.61%的年複合成長率成長,2023年達到9億美元的規模。市場成長的主要原因,是高齡化人口的增加和經濟成長率的上升,PCI的普及,醫療費用支出的總額,STEMI患者的增加,肥胖人口的增加,心臟疾病患者的增加等。市場根據品牌的期限可分類為外資、國內的2種,不過,一般認為國內品牌由於價格競爭力和迅速的技術力提高將獲得市場占有率。另一方面,PCI支援設備 (血管造影術導管導引線,血管造影術導管,引導管,微導管導引線,膨脹設備等)的需求也正在擴大。

本報告提供中國國內的冠狀動脈介入治療 (CI) 設備及經皮冠狀動脈介入治療 (PCI) 設備的市場相關分析,整體市場規模趨勢預測 (過去、今後5年份) ,及各品牌、各分類的詳細趨勢,主要的推動及阻礙市場要素和背景情況 (患者數等),企業間的競爭狀態、業績比較,主要企業簡介等調查。

第1章 市場概要

  • 冠狀動脈疾病(CAD)
  • CAD的診斷方法
  • CAD的治療方法
  • 經皮冠狀動脈介入治療 (PCI)
  • 經皮冠狀動脈介入治療 (PCI)的次序
  • 經皮冠狀動脈介入治療 (PCI)的風險
  • PCI支援設備
  • 手術中所使用的PCI設備

第2章 市場分析

  • 中國的CI設備市場 (以金額為準)
  • 中國的CI設備市場,預測值 (以金額為準)
  • 中國的CI設備市場:品牌的各種類的市場佔有率
  • 中國的CI設備市場:國際品牌
  • 中國的CI設備市場:國際品牌,預測值
  • 中國的CI設備市場:國內品牌
  • 中國的CI設備市場:國內品牌,預測值
  • 中國的CI支援設備的市場:各類別
  • 中國的PCI設備市場 (以金額為準)
  • 中國的PCI設備市場,預測值 (以金額為準)
  • 中國的PCI設備市場:各品牌佔有率
  • 中國的PCI設備市場:國際品牌
  • 中國的PCI設備市場:國際品牌,預測值
  • 中國的PCI設備市場:國內品牌
  • 中國的PCI設備市場:國內品牌,預測值
  • 中國國內的PCI治療數量
  • 中國國內的PCI治療數量,預測值
  • 中國的PCI支援設備的市場:各類別
  • 中國的支架置入數量 (每1次PCI手術)
  • 接受中國的PCI手術:治療的患者的種類
  • 中國的STEMI患者裡面,受到PPCI治療的比率
  • 中國的STEMI患者裡面,受到PPCI治療的比率

第3章 市場動態

  • 成長促進因素
    • 高齡化人口的增加
    • PCI普及率的上升
    • 醫療費的增加
    • STEMI患者的增加
    • 經濟發展的加速
    • 肥胖人口的增加
    • 心臟疾病患者的增加
  • 主要趨勢和動靜
    • 速食的消費增加
    • AMI的發生率上升
    • 微創手術的需求增加
  • 課題
    • 嚴格的政府法規
    • 感染的風險

第5章 競爭環境

  • 全球市場
    • 市場收益額比較:主要企業間
    • 股票市值比較:主要企業間

第5章 企業簡介

  • MicroPort Scientific Corporation
    • 產業概要
    • 主要的財務指標
    • 事業策略
  • Lifetech Scientific Corporation
  • Terumo Corporation
  • Boston Scientific
  • Abbott Laboratories
  • Johnson & Johnson
目錄

China PCI devices market is estimated to reach US$0.90 billion in 2023, growing at a CAGR of 11.61% for the period spanning from 2020 to 2024. The factors such as increasing aging population, accelerating economic growth, rising prevalence of PCI, increasing healthcare expenditure, rising STEMI patients, growing obese population and increasing number of cardiac diseases are expected to drive the market. However, growth of the industry will be challenged by strict government regulations and risk of infection. A few notable trends include consumption of fast food, rising incidence of AMI and increasing demand for minimally invasive procedures.

China CI & PCI devices market is segmented by origin into two Domestic and International brands. Domestic brands are estimated to gain market share owing to competitive pricing and improving technology. The volume of PCI procedures increased rapidly driven by increasing incidences of acute myocardial infraction due to aging population and changing lifestyle.

PCI supporting devices include angiography guidewire, angiography catheter, guiding catheter, micro-guidewire, and inflation device. Many types of supporting devices are needed during PCI procedure to deliver balloon catheters and stents to the blockage site. Rise in the number of qualified hospitals for PCI surgery and growing healthcare expenditure are likely to impact the PCI supporting devices demand in China.

Scope of the report:

The report provides a comprehensive analysis of China CI & PCI devices market, segmented by origin into two segments: Domestic and International brands.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (MicroPort Scientific Corporation, Lifetech Scientific Corporation, Terumo Corporation, Boston Scientific, Abbott Laboratories & Johnson & Johnson) are also presented in detail.

Key Target Audience:

  • Device Manufacturers
  • Raw Material/Component Suppliers
  • End Users (Hospitals, Medical Centers & Clinical Institutes)
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Coronary Artery Disease (CAD)
  • 1.2 CAD Diagnosis
  • 1.3 CAD Treatment
  • 1.4 Percutaneous Coronary Intervention (PCI)
  • 1.5 Percutaneous Coronary Intervention (PCI) Procedure
  • 1.6 Risks of Percutaneous Coronary Intervention (PCI)
  • 1.7 PCI Supporting Devices
  • 1.8 PCI Devices Used During Procedure

2. Market Analysis

  • 2.1 China CI Device Market by Value
  • 2.2 China CI Device Market Forecast by Value
  • 2.3 China CI Device Market Share by Brand Origin
  • 2.4 China CI Device International Brands Market
  • 2.5 China CI Device International Brands Market Forecast
  • 2.6 China CI Device Domestic Brands Market
  • 2.7 China CI Device Domestic Brands Market Forecast
  • 2.8 China CI Supporting Device Market by Category
  • 2.9 China PCI Device Market by Value
  • 2.10 China PCI Device Market Forecast by Value
  • 2.11 China PCI Device Market Share by Brand Origin
  • 2.12 China PCI Device International Brands Market
  • 2.13 China PCI Device International Brands Market Forecast
  • 2.14 China PCI Device Domestic Brands Market
  • 2.15 China PCI Device Domestic Brands Market Forecast
  • 2.16 China PCI Procedure
  • 2.17 China PCI Procedure Forecast
  • 2.18 China PCI Supporting Device Market by Category
  • 2.19 China Stent Implantation per PCI Surgery
  • 2.20 China Patients Type Treated by PCI Surgeries
  • 2.21 China % of STEMI Patients with PPCI Treatment
  • 2.22 China % of STEMI Patients with PPCI Treatment

3. Market Dynamics

  • 3.1 Growth Drivers
    • 3.1.1 Rising Ageing Population
    • 3.1.2 Increasing of PCI Prevalence
    • 3.1.3 Rising Healthcare Expenditure
    • 3.1.4 Increasing STEMI Patients
    • 3.1.5 Accelerating Economic Growth
    • 3.1.6 Increase in Obese Population
    • 3.1.7 Growing Number of Cardiac Diseases
  • 3.2 Key Trends & Developments
    • 3.2.1 Growing Consumption of Fast Food
    • 3.2.2 Rising Incidence of AMI
    • 3.2.3 Increasing Demand for Minimally Invasive Procedures
  • 3.3 Challenges
    • 3.3.1 Strict Government Regulations
    • 3.3.2 Risk of Infections

4. Competitive Landscape

  • 4.1 Global Market
    • 4.1.1 Revenue Comparison of Key Players
    • 4.1.2 Market Cap Comparison of Key Players

5. Company Profiles

  • 5.1 MicroPort Scientific Corporation
    • 5.1.1 Business Overview
    • 5.1.2 Financial Overview
    • 5.1.3 Business Strategies
  • 5.2 Lifetech Scientific Corporation
    • 5.2.1 Business Overview
    • 5.2.2 Financial Overview
    • 5.2.3 Business Strategies
  • 5.3 Terumo Corporation
    • 5.3.1 Business Overview
    • 5.3.2 Financial Overview
    • 5.3.3 Business Strategies
  • 5.4 Boston Scientific
    • 5.4.1 Business Overview
    • 5.4.2 Financial Overview
    • 5.4.3 Business Strategies
  • 5.5 Abbott Laboratories
    • 5.5.1 Business Overview
    • 5.5.2 Financial Overview
    • 5.5.3 Business Strategies
  • 5.6 Johnson & Johnson
    • 5.6.1 Business Overview
    • 5.6.2 Financial Overview
    • 5.6.3 Business Strategies

List of Figures

  • PCI Devices Used During Procedure
  • China CI Device Market by Value (2015-2019)
  • China CI Device Market Forecast by Value (2020-2024)
  • China CI Device Market Share by Brand Origin (2019)
  • China CI Device International Brands Market (2015-2019)
  • China CI Device International Brands Market Forecast (2020-2024)
  • China CI Device Domestic Brands Market (2015-2019)
  • China CI Device Domestic Brands Market Forecast (2020-2024)
  • China CI Supporting Device Market by Category (2019)
  • China PCI Device Market by Value (2015-2019)
  • China PCI Device Market Forecast by Value (2020-2024)
  • China PCI Device Market Share by Brand Origin (2019)
  • China PCI Device International Brands Market (2015-2019)
  • China PCI Device International Brands Market Forecast (2020-2024)
  • China PCI Device Domestic Brands Market (2015-2019)
  • China PCI Device Domestic Brands Market Forecast (2020-2024)
  • China PCI Procedure (2015-2019)
  • China PCI Procedure Forecast (2020-2024)
  • China PCI Supporting Device Market by Category (2019)
  • China Stent Implantation per PCI Surgery (2015-2019)
  • China Patients Type Treated by PCI Surgeries (2019)
  • China % of STEMI Patients with PPCI Treatment (2015-2019)
  • China % of STEMI Patients with PPCI Treatment (2020-2024)
  • China Ageing Population (2015-2019)
  • Penetration of PCI Procedure in China (2019)
  • China Health Expenditure as a Share of GDP (2015-2019)
  • Number of STEMI Patients in China (2015-2019)
  • China GDP Per Capita (2015-2019)
  • MicroPort Revenue by Segment (2018)
  • MicroPort Revenue by Geographic Regions (2018)
  • MicroPort Revenue and Net Profit (2014-2018)
  • Lifetech Scientific Revenue by Segments (2018)
  • Lifetech Scientific Revenue by Region (2018)
  • Lifetech Scientific Revenue and Profit (Loss) (2014-2018)
  • Terumo Corporation Sales by Product Category (2019)
  • Terumo Corporation Sales and Profit (2015-2019)
  • Boston Scientific Net Sales by Segment (2019)
  • Boston Scientific Medical Devices Net Sales by Region (2019)
  • Boston Scientific Specialty Pharmaceuticals Net Sales by Region (2019)
  • Boston Scientific Net Sales and Net Income (2015-2019)
  • Abbott Laboratories Net Sales by Segments (2019)
  • Abbott Laboratories Net Sales by Country (2019)
  • Abbott Laboratories Net Sales and Net Earnings (2015-2019)
  • Johnson & Johnson Sales by Segments (2019)
  • Johnson & Johnson Sales by Region (2019)
  • Johnson & Johnson Sales and Net Earnings (2015-2019)

List of Tables

  • Diagnoses of Coronary Artery Disease (CAD)
  • PCI Supporting Devices
  • Revenue Comparison of Key Players (2018/2019)
  • Market Cap Comparison of Key Players (2019)